Search Results

Filter
  • 1-10 of  241,538 results for ""Azathioprine""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

[Effectiveness and tolerance of azathioprine as first-line treatment for multiple sclerosis: a case study from Morocco].

  • Authors : Mirhani A; Laboratoire de Biologie et Santé, Faculté des Sciences, Université Ibn-Tofail, Kenitra, Maroc.; Auajjar N

Subjects: Azathioprine*/Azathioprine*/Azathioprine*/administration & dosage ; Immunosuppressive Agents*/Immunosuppressive Agents*/Immunosuppressive Agents*/administration & dosage ; Multiple Sclerosis, Relapsing-Remitting*/Multiple Sclerosis, Relapsing-Remitting*/Multiple Sclerosis, Relapsing-Remitting*/drug therapy

  • Source: The Pan African medical journal [Pan Afr Med J] 2024 Sep 18; Vol. 49, pp. 16. Date of Electronic Publication: 2024 Sep 18 (Print Publication: 2024).Publisher: African Field Epidemiology Network Country of Publication: Uganda NLM ID: 101517926 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Efficacy and safety of azathioprine in patients with Cronkhite-Canada syndrome: a case series from Peking Union Medical College Hospital.

  • Authors : Xu Q; Department of Gastroenterology, Chinese Academy of Medical Sciences, Peking Union Medical College Hospital, No.1 Shuaifuyuan Wangfujing Dongcheng District, Beijing, 100730, China.; Jin L

Subjects: Azathioprine*/Azathioprine*/Azathioprine*/therapeutic use ; Azathioprine*/Azathioprine*/Azathioprine*/adverse effects ; Immunosuppressive Agents*/Immunosuppressive Agents*/Immunosuppressive Agents*/therapeutic use

  • Source: BMC pharmacology & toxicology [BMC Pharmacol Toxicol] 2024 Dec 18; Vol. 25 (1), pp. 96. Date of Electronic Publication: 2024 Dec 18.Publisher: BioMed Central Country of Publication: England NLM ID: 101590449 Publication Model: Electronic Cited Medium: Internet ISSN: 2050-6511

Record details

×
Academic Journal

Analysis of Azathioprine Metabolites in Autoimmune Hepatitis Patient Blood-Method Development and Validation.

  • Authors : Guba A; Proteomics Core Facility, Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, Egyetem tér 1, 4032 Debrecen, Hungary.; Metabolomics Research Group, Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, Egyetem tér 1, 4032 Debrecen, Hungary.

Subjects: Azathioprine*/Azathioprine*/Azathioprine*/therapeutic use ; Azathioprine*/Azathioprine*/Azathioprine*/blood ; Azathioprine*/Azathioprine*/Azathioprine*/metabolism

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Oct 18; Vol. 25 (20). Date of Electronic Publication: 2024 Oct 18.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

×
Academic Journal

Azathioprine for people with multiple sclerosis.

  • Authors : Ridley B; IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.; Nonino F

Subjects: Azathioprine*/Azathioprine*/Azathioprine*/therapeutic use ; Azathioprine*/Azathioprine*/Azathioprine*/adverse effects ; Randomized Controlled Trials as Topic*

  • Source: The Cochrane database of systematic reviews [Cochrane Database Syst Rev] 2024 Dec 09; Vol. 12. Cochrane AN: CD015005. Date of Electronic Publication: 2024 Dec 09.Publisher: Wiley Country of Publication: England NLM ID: 100909747 Publication Model: Electronic Cited Medium: Internet ISSN: 1469-493X

Record details

×
Academic Journal

Erythema Multiforme-Like Fixed Drug Eruption During Azathioprine and Hydroxychloroquine Treatment for Systemic Lupus Erythematosus Mimicking Rowell Syndrome: A Rare and Challenging Clinical Scenario.

  • Authors : Shaker N; Pathology and Laboratory Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA.; Sangueza OP

Subjects: Lupus Erythematosus, Systemic*/Lupus Erythematosus, Systemic*/Lupus Erythematosus, Systemic*/diagnosis ; Lupus Erythematosus, Systemic*/Lupus Erythematosus, Systemic*/Lupus Erythematosus, Systemic*/drug therapy ; Lupus Erythematosus, Systemic*/Lupus Erythematosus, Systemic*/Lupus Erythematosus, Systemic*/chemically induced

  • Source: International journal of surgical pathology [Int J Surg Pathol] 2024 Dec; Vol. 32 (8), pp. 1485-1490. Date of Electronic Publication: 2024 Mar 18.Publisher: Sage Publications Country of Publication: United States NLM ID: 9314927 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Ten-year follow-up cohort of the everolimus versus azathioprine multinational prospective study focusing on intravascular ultrasound findings.

  • Authors : Kim IC; Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California; Division of Cardiology, Department of Internal Medicine, Keimyung University Dongsan Hospital, Keimyung University School of Medicine, Daegu, Republic of Korea.

Subjects: Everolimus*/Everolimus*/Everolimus*/therapeutic use ; Ultrasonography, Interventional*/Ultrasonography, Interventional*/Ultrasonography, Interventional*/methods ; Immunosuppressive Agents*/Immunosuppressive Agents*/Immunosuppressive Agents*/therapeutic use

  • Source: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation [J Heart Lung Transplant] 2024 Nov; Vol. 43 (11), pp. Publisher: Elsevier Country of Publication: United States NLM ID: 9102703 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Case report: Partial regression of metastatic squamous cell carcinoma with altered azathioprine dosage after long-term use in renal transplant patient.

Subjects: Azathioprine*/Azathioprine*/Azathioprine*/administration & dosage ; Azathioprine*/Azathioprine*/Azathioprine*/therapeutic use ; Kidney Transplantation*/Kidney Transplantation*/Kidney Transplantation*/adverse effects

  • Source: Frontiers in immunology [Front Immunol] 2024 Oct 31; Vol. 15, pp. 1474663. Date of Electronic Publication: 2024 Oct 31 (Print Publication: 2024).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Comparison of efficacy and safety of tofacitinib and azathioprine in patients with alopecia areata and variants: a double-blind, randomized controlled trial.

  • Authors : Paracha M; Department of Dermatology, Medical Teaching Institute-Lady Reading Hospital (MTI-LRH), Peshawar, Pakistan. .; Wasim M

Subjects: Alopecia Areata*/Alopecia Areata*/Alopecia Areata*/drug therapy ; Alopecia Areata*/Alopecia Areata*/Alopecia Areata*/diagnosis ; Azathioprine*/Azathioprine*/Azathioprine*/administration & dosage Alopecia universalis

  • Source: Archives of dermatological research [Arch Dermatol Res] 2024 Jul 05; Vol. 316 (7), pp. 458. Date of Electronic Publication: 2024 Jul 05.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8000462 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-069X

Record details

×
Academic Journal

Azathioprine Plus Exclusive Enteral Nutrition Versus Azathioprine Monotherapy for the Prevention of Postoperative Recurrence in Patients with Crohn's Disease: An Open-Label, Single-Centre, Randomized Controlled Trial.

  • Authors : Duan M; Department of General Surgery, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210002, China.; Lu M

Subjects: Crohn Disease*/Crohn Disease*/Crohn Disease*/therapy ; Crohn Disease*/Crohn Disease*/Crohn Disease*/surgery ; Crohn Disease*/Crohn Disease*/Crohn Disease*/prevention & control

  • Source: Journal of Crohn's & colitis [J Crohns Colitis] 2024 Aug 06; Vol. 18 (7), pp. 1113-1121.Publisher: Oxford University Press Country of Publication: England NLM ID: 101318676 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Effectiveness and Safety of Azathioprine versus PUVA-SOL as Steroid-Sparing Agents in the Treatment of Unstable Vitiligo.

  • Authors : Nagar R; Department of Dermatology, Mahatma Gandhi Medical College & Maharaja Yashwant Rao Hospital, Indore, Madhya Pradesh, India.; Mandloi U

Subjects: Vitiligo*/Vitiligo*/Vitiligo*/drug therapy ; PUVA Therapy*/PUVA Therapy*/PUVA Therapy*/methods ; Azathioprine*/Azathioprine*/Azathioprine*/therapeutic use

  • Source: Skinmed [Skinmed] 2024 Sep 17; Vol. 22 (4), pp. 276-280. Date of Electronic Publication: 2024 Sep 17 (Print Publication: 2024).Publisher: Pulse Marketing & Communications Country of Publication: United States NLM ID: 101168327 Publication Model: eCollection Cited Medium:

Record details

×
  • 1-10 of  241,538 results for ""Azathioprine""